2,0
19 mag 2026
Ex dipendente, più di 3 anni
Poona
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Good infrastructure in R&D, manufacturing, robust compliance set up.
Svantaggi
Compared to Pharma biologics seems weak. Long timelines from inception to market delivery. In comparison, other Indian biosimilar sponsors have gone far ahead.